Drug Therapy monitoring documentation help????


Lake Charles, LA
Best answers
For Drug Therapy requiring intensive monitoring what needs to be documented? Do providers need to specify what they are monitoring for? Below is example of documentation and I am not sure if this would qualify since specific monitoring is not documented.

Provider is seeing patient for 4 mnth follow up for PET/CT results and CBC and CHEM 18 results, no new complaints, treating for stage 4 Breast cancer. Provider treating patient with Ibrance/AI. Provider reviewed PET/CT findings of left upper lobe nodule SUV 3.7 asymptomatic and CBC and CHEM 18 was reviewed. Discussed changing therapy and agreed to repeat PET in 2 months and decision to be made then regarding therapy. Pending PET results may change therapy to Ibrance/Faslodex. Patient to return in 2 months after PET/CT.

Does this meet qualifications for Drug Therapy requiring montioring?